The long-term goal of this proposal is to elucidate the molecular mechanism controlling mammalian foregut and early liver development. The largest exocrine gland in the body the liver produces bile and is the primary site for detoxification. It also performs important endocrine functions by secreting homeostatic blood proteins and regulating glucose levels through glycogen storage. A recent trans-NIH report """"""""Action Plan for Liver Disease Research (2004)"""""""" recognized that a better understanding of embryonic liver development would provide important insights into human liver disease and promote our ability to harness embryonic stem cells as a renewable source of tissue for transplantation. The mouse embryonic liver is induced from the ventral foregut endoderm by Fgf signals from the cardiac mesoderm. While we increasingly understand the genetic pathways regulating proliferation and differentiation of hepatoblasts after the liver bud has formed, the earlier events linking endoderm patterning to hepatic specification are less clear. In Xenopus we recently determined that differential Wnt/?eta-catenin signaling regulates endoderm fates. Our data supports a model where during gastrula and early somite stages secreted Wnt- antagonists in the anterior endoderm establish foregut identity and initiate a molecular cascade leading to liver development. In contrast, the posterior endoderm has high ?eta-catenin activity, due to Wnt ligands secreted from the lateral/axial mesoderm, which represses foregut fate and promotes intestinal development. We propose to test this hypothesis using mouse genetics and embryonic explants to characterize the underlying molecular mechanism. Moreover, we will investigate whether analogous pathways are important for liver development in humans using endoderm cultures derived from human embryonic stem cells. The results of this proposal will directly impact efforts to generate therapeutically useful endoderm tissue for the treatment of liver disease in humans.
Aim 1. Determine if repression of ?eta-catenin activity in the anterior endoderm is required for foregut and liver development using mouse genetics.
Aim 2. Define when ?eta-catenin needs to be repressed and examine how the temporally distinct Wnt and Fgf pathways interact during hepatic development, using mouse embryonic explant cultures.
Aim 3. Investigate the role of Wnt signaling in promoting human foregut and liver lineages from HESCs

Public Health Relevance

The liver is a vital organ providing many essential functions and numerous diseases are so life threatening that liver transplantation is the only option. The differentiation of liver cells from embryonic stem cells is a potentially renewable source of tissue for transplantation. The goal of this proposal is to elucidate the genetic programs controlling embryonic liver development in mice. We will then use this information to recapitulating the key embryonic events in human embryonic stem cells to more effectively generate liver tissue in culture.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Gastrointestinal Cell and Molecular Biology Study Section (GCMB)
Program Officer
Carrington, Jill L
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Cincinnati Children's Hospital Medical Center
United States
Zip Code
McGrath, Patrick S; Watson, Carey L; Ingram, Cameron et al. (2015) The Basic Helix-Loop-Helix Transcription Factor NEUROG3 Is Required for Development of the Human Endocrine Pancreas. Diabetes 64:2497-505
Sinagoga, Katie L; Wells, James M (2015) Generating human intestinal tissues from pluripotent stem cells to study development and disease. EMBO J 34:1149-63
McCracken, Kyle W; Catá, Emily M; Crawford, Calyn M et al. (2014) Modelling human development and disease in pluripotent stem-cell-derived gastric organoids. Nature 516:400-4
Schiesser, Jacqueline V; Wells, James M (2014) Generation of ? cells from human pluripotent stem cells: are we there yet? Ann N Y Acad Sci 1311:124-37
Chlon, Timothy M; Hoskins, Elizabeth E; Mayhew, Christopher N et al. (2014) High-risk human papillomavirus E6 protein promotes reprogramming of Fanconi anemia patient cells through repression of p53 but does not allow for sustained growth of induced pluripotent stem cells. J Virol 88:11315-26
Jonatan, Diva; Spence, Jason R; Method, Anna M et al. (2014) Sox17 regulates insulin secretion in the normal and pathologic mouse ? cell. PLoS One 9:e104675
Brugmann, Samantha A; Wells, James M (2013) Building additional complexity to in vitro-derived intestinal tissues. Stem Cell Res Ther 4 Suppl 1:S1
McCracken, Kyle W; Wells, James M (2012) Molecular pathways controlling pancreas induction. Semin Cell Dev Biol 23:656-62
Du, Aiping; McCracken, Kyle W; Walp, Erik R et al. (2012) Arx is required for normal enteroendocrine cell development in mice and humans. Dev Biol 365:175-88
McCracken, Kyle W; Howell, Jonathan C; Wells, James M et al. (2011) Generating human intestinal tissue from pluripotent stem cells in vitro. Nat Protoc 6:1920-8

Showing the most recent 10 out of 15 publications